跳至主要内容
临床试验/NCT06047912
NCT06047912招募中不适用

Screening for Primary Aldosteronism in Hypertension With 24-hour URinary aLdosterone

Dr Ian B Wilkinson1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120
试验地点
1
主要终点
Degree of agreement between a positive/negative ARR and a positive/negative 24-hr urine aldosterone

研究概览

简要总结

This is an observational study compares the positivity rates of two tests for screening for primary aldosteronism: plasma aldosterone renin ratio and 24-hour urine aldosterone in patients with young-onset hypertension with or without other clinical features of primary aldosteronism.

详细描述

Plasma aldosterone and renin measurements are subject to significant intra-individual variability, including variation related to posture, time of day and sodium balance. Aldosterone secretion is not constant and may be subject to diurnal variation. As such one-off testing of ARR, does not consider the salt status of the individual necessitating repetition of tests to ensure false negative or false positive test results are ruled out. The value of accumulated aldosterone in a 24-hour sample has the advantage that it does not depend on circadian variation. This pilot observational study will help establish the positivity rates of both standard plasma aldosterone renin ratio and 24-hour urine aldosterone, and the degree to which they correlate but will help establish if untargeted screening in young-onset hypertension is feasible and test the robustness of current standard guidelines for primary aldosteronism screening and case confirmation.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A patient will be eligible for inclusion in this trial only if all of the following criteria apply:
  • Aged 18 years and above.
  • Meets NICE criteria for a diagnosis of hypertension with an age of onset of hypertension between 18-60 years.
  • For cohort 2 (suspected primary aldosteronism): resistant hypertension, and/or hypertension with spontaneous or diuretic-induced hypokalaemia, and/or hypertension.

排除标准

  • • Severe hypertension (sustained blood pressure of >200/110 mmHg) or a history of known secondary hypertension other than PA.
  • Contraindications to confirmatory testing with saline infusion or oral salt loading test as per standard clinical criteria such as known clinical diagnosis of heart failure, and/or chronic kidney disease stage 3b.
  • Known Pregnancy or breast feeding.
  • Lack of informed consent.
  • Any medical condition deemed unsuitable by investigator for participation in the study

结局指标

主要结局

Degree of agreement between a positive/negative ARR and a positive/negative 24-hr urine aldosterone

时间窗: 1 year

Rates of positive and negative, Aldosterone renin ratio and 24-hr urine aldosterone in unselected patients with hypertension and in patients with suspected primary aldosteronism

时间窗: 1 year

次要结局

  • Number of patients who required oral salt loading(1 year)
  • The predictive value of a positive aldosterone renin ratio or 24-hr urine aldosterone with a positive confirmatory test(1 year)

研究者

发起方
Dr Ian B Wilkinson
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr Ian B Wilkinson

Chief Investigator

Cambridge University Hospitals NHS Foundation Trust

研究点 (1)

Loading locations...

相似试验